天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2013年
11期
1070-1072
,共3页
侯安丽%李秀芬%张雅丽%杨冬蕊%苏晓霞
侯安麗%李秀芬%張雅麗%楊鼕蕊%囌曉霞
후안려%리수분%장아려%양동예%소효하
宫颈肿瘤%癌,鳞状细胞%Wnt1蛋白质%免疫组织化学%DKK1%分泌型卷曲相关蛋白4
宮頸腫瘤%癌,鱗狀細胞%Wnt1蛋白質%免疫組織化學%DKK1%分泌型捲麯相關蛋白4
궁경종류%암,린상세포%Wnt1단백질%면역조직화학%DKK1%분비형권곡상관단백4
uterine cervical neoplasms%carcinoma,squamous cell%Wnt1 protein%immunohistochemistry%dickkopf 1%SFRP4
目的:研究Wnt信号通路抑制因子DKK1、分泌型卷曲相关蛋白(SFRP)4及Wnt基因家族因子(Wnt1)在宫颈鳞癌中的表达及其临床意义。方法76例宫颈癌患者病理标本为SCC组,36例子宫良性肿瘤切除标本为对照组(NC组),应用免疫组化法检测DKK1、SFRP4及Wnt1在SCC组及NC组中的表达。结果 DKK1在SCC组的表达低于NC组(P<0.05)。SFRP4及Wnt1在SCC组的表达均高于NC组(P<0.05)。DKK1、SFRP4及Wnt1在不同临床病理分期、组织分化程度、肿瘤大小及有无淋巴结转移SCC患者间表达差异有统计学意义(均P<0.05)。宫颈鳞癌中DKK1与SFRP4、Wnt1的表达均呈负相关(均P<0.05),SFRP4与Wnt1在宫颈鳞癌中的表达呈正相关(P<0.05)。结论 SFRP4和Wnt1在宫颈鳞癌的发生中可能存在协同作用,而DKK1可能作为宫颈鳞癌的抑制因子发挥作用。
目的:研究Wnt信號通路抑製因子DKK1、分泌型捲麯相關蛋白(SFRP)4及Wnt基因傢族因子(Wnt1)在宮頸鱗癌中的錶達及其臨床意義。方法76例宮頸癌患者病理標本為SCC組,36例子宮良性腫瘤切除標本為對照組(NC組),應用免疫組化法檢測DKK1、SFRP4及Wnt1在SCC組及NC組中的錶達。結果 DKK1在SCC組的錶達低于NC組(P<0.05)。SFRP4及Wnt1在SCC組的錶達均高于NC組(P<0.05)。DKK1、SFRP4及Wnt1在不同臨床病理分期、組織分化程度、腫瘤大小及有無淋巴結轉移SCC患者間錶達差異有統計學意義(均P<0.05)。宮頸鱗癌中DKK1與SFRP4、Wnt1的錶達均呈負相關(均P<0.05),SFRP4與Wnt1在宮頸鱗癌中的錶達呈正相關(P<0.05)。結論 SFRP4和Wnt1在宮頸鱗癌的髮生中可能存在協同作用,而DKK1可能作為宮頸鱗癌的抑製因子髮揮作用。
목적:연구Wnt신호통로억제인자DKK1、분비형권곡상관단백(SFRP)4급Wnt기인가족인자(Wnt1)재궁경린암중적표체급기림상의의。방법76례궁경암환자병리표본위SCC조,36례자궁량성종류절제표본위대조조(NC조),응용면역조화법검측DKK1、SFRP4급Wnt1재SCC조급NC조중적표체。결과 DKK1재SCC조적표체저우NC조(P<0.05)。SFRP4급Wnt1재SCC조적표체균고우NC조(P<0.05)。DKK1、SFRP4급Wnt1재불동림상병리분기、조직분화정도、종류대소급유무림파결전이SCC환자간표체차이유통계학의의(균P<0.05)。궁경린암중DKK1여SFRP4、Wnt1적표체균정부상관(균P<0.05),SFRP4여Wnt1재궁경린암중적표체정정상관(P<0.05)。결론 SFRP4화Wnt1재궁경린암적발생중가능존재협동작용,이DKK1가능작위궁경린암적억제인자발휘작용。
Objective To investigate the expressions of DKK1,SFRP4 and Wnt1 in cervical squamous cell carcino-ma(SCC), and the clinical significance thereof. Methods There were 76 samples of cervical squamous cell carcinoma were included in SCC group and 36 benign uterine resection specimens were control group (NC). The immunohistochemical meth-od was applied to detect the expressions of DKK1,SFRP4 and Wnt1 in two groups. Results The expression of DKK1 was significantly lower in SCC group than that in NC group (P<0.05). The expression levels of SFRP4 and Wnt1 were significant-ly higher in SCC group than those of NC group (P<0.05). There were significant differences in the expressions of DKK1, SFRP4 and Wnt1 between samples of different clinical staging, differentiation, sizes of tumor and lymph node metastasis (P<0.05). The expression of DKK1 was negatively correlated with SFRP4 and Wnt1 in SCC group (P<0.05). The expression of SFRP4 was positively correlated with Wnt1 in SCC group (P<0.05). Conclusion The roles of SFRP4 and Wnt1 are syn-ergistic interactions in the development of SCC. DKK1 is an inhibiting factor of SCC.